Need help finding what you are looking for?
Contact Us
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2075108
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2075108
Europe Pharmaceutical Drugs Market,Drug Type, by Product Type, by Application, by Distribution Channel and by Country -
PUBLISHED:
PAGES: 250+ Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Europe Pharmaceutical Drugs Market is estimated to be valued at USD 206.03 Bn in 2026 and is expected to reach USD 284.15 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 206.03 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.70% | 2033 Value Projection: | USD 284.15 Bn |
Pharmaceutical drugs are used for the treatment of chronic and acute diseases. There are two types of pharmaceutical drugs: generic and branded, which are sold through prescription and over the counter (OTC). A pharmaceutical drug that shares the same chemical component as a drug that was originally covered by chemical patents is known as a generic drug.Generic drugs are allowed for sale after the patents on the original drugs expire.Generics perform similarly in terms of the medical profile due to the identical active chemical substance. Generic drugs are similar to branded drugs and are less expensive as compared to branded drugs.
Increasing prevalence of diseases such as cardiovascular disorders, cancer, and metabolic disorders, as well as product launches, patent expiration of branded drugs, and other diseases, and the presence of favorable reimbursement policies are expected to increase demand for the pharmaceutical drug market in Europe during the forecast period. A brand drug is the innovator drug and gets patent and exclusivity protection. Pharmaceutical drugs are composed of chemical compounds which are used for the prevention and treatment of diseases and are administered intravenously, orally, intramuscularly, or by other routes of administration. Pharmaceutical drugs are of two types; generic and branded. Pharmaceutical drugs are subjected to numerous regulations with respect to patenting, clinical trials, drug safety, efficacy, and marketing in Europe region.
Market Dynamics
The patent expiry of branded products is paving the way for the entry of generic drugs into the market. Moreover, adoption of inorganic and organic strategies such as mergers and acquisitions, and product developments by key players to expand their product portfolio is expected to drive the growth of the Europe pharmaceutical drugs market. For instance, on January 2020, Novartis AG- a U.S based biopharmaceutical company, received the European Commission's approval for MAyznet for the treatment of secondary progressive multiple sclerosis (SPMS) in adult patients.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players.
- It profiles key players in the Europe pharmaceutical drugs market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans.
- Major players operating in the Europe pharmaceutical drugs market are Allergan plc. (A subsidiary of AbbVie Inc.),Novo Nordisk A/S, Boehringer Ingelheim, Merck KGaA, GlaxoSmithKline plc., AstraZeneca., Baxter, Novartis AG, F. Hoffmann-La Roche Ltd, Shire (A subsidiary of Takeda Pharmaceutical Company Limited), and Sanofi.
- Insights from this report would allow marketers and management authorities of the companies to make informed decisions regarding future product launches, technology up-gradation, market expansion, and marketing tactics.
- The Europe pharmaceutical drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Europe pharmaceutical drugs market .
Detailed Segmentation:
- Europe Pharmaceutical Drugs Market, By Drug Type (Revenue, USD Bn, 2021 - 2033)
- Generic Drugs
- Branded Drugs
- Europe Pharmaceutical Drug Market, By Product Type (Revenue, USD Bn, 2021 - 2033)
- Prescription Drugs
- Over-the-counter (OTC) Drugs
- Europe Pharmaceutical Drug Market, By Application (Revenue, USD Bn, 2021 - 2033)
- Cardiovascular
- Musculoskeletal
- Oncology
- Anti-infective
- Metabolic Disorder
- Central Nervous System
- Genito-urinary
- Gastrointestinal
- Respiratory
- Hematology
- Dermatology
- Ophthalmology
- Others
- Europe Pharmaceutical Drug Market, By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Europe Pharmaceutical Drug Market, By Country (Revenue, USD Bn, 2021 - 2033)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Netherlands
- Poland
- Switzerland
- Sweden
- Rest of Europe
- Company Profiles
- Allergan plc (A subsidiary of AbbVie Inc.)
- Novo Nordiska A/S
- Boehringer Ingelheim International GmbH
- Merck KGaA
- GSK Plc.
- AstraZeneca
- Baxter
- Novartis AG
- Hoffmann-La Roche Ltd
- Shire (A subsidary of Takeda Pharmaceutical Company Limited)
- Sanofi
Product Code: CMI3541
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Country
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Regulatory scenario
- Key Developments
- Industry trends
- PEST Analysis
- Epidemiology
- Reimbursement scenario
4. Europe Pharmaceutical Drugs Market, By Drug Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 - 2033(%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Generic Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Branded Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
5. Europe Pharmaceutical Drugs Market, By Product Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 - 2033(%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Prescription drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- OTC drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
6. Europe Pharmaceutical Drugs Market, By Application, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 - 2033(%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Cardiovascular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Musculoskeletal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Anti-infective
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Metabolic disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Central Nervous System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Genito-urinary
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Gastrointestinal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Respiratory
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Hematology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Dermatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Ophthalmology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
7. Europe Pharmaceutical Drugs Market, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2026 - 2033(%)
- Y-o-Y Growth Analysis, For Regions, 2022 - 2033
- Segment Trends
- Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y , 2021 - 2033 Growth
- Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033 (US$ Bn)
- Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
8. Europe Pharmaceutical Drugs Market, By Country, 2021-2033, (US$Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- UK
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- France
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Germany
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Italy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Spain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Russia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Netherlands
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Poland
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Switzerland
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Sweden
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021- 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Rest of Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021- 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
9. Competitive Landscape
- Company Profiles
- Allergan plc (A subsidiary of AbbVie Inc.)
- Company Highlights
- Product form Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novo Nordisk A/S
- Company Highlights
- Product form Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Boehringer Ingelheim International GmbH
- Company Highlights
- Product form Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck KGaA
- Company Highlights
- Product form Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GSK plc
- Company Highlights
- Product form Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Baxter
- Company Highlights
- Product form Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Product form Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Hoffman- La Roche Limited .
- Company Highlights
- Product form Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Shire (A subsidiary of Takeda Pharmaceutical Company Limited)
- Company Highlights
- Product form Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sanofi
- Company Highlights
- Product form Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Allergan plc (A subsidiary of AbbVie Inc.)
10. Section
- Research Methodology
- About Us and sales contact
- References
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.